Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease

BACKGROUND: Biological therapies have been introduced for the treatment of chronic inflammatory diseases including rheumatoid arthritis (RA) and Crohn's disease (CD). The efficacy of biologics differs from patient to patient. Moreover these therapies are rather expensive, therefore treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesko, Bertalan, Poliska, Szilard, Váncsa, Andrea, Szekanecz, Zoltan, Palatka, Karoly, Hollo, Zsolt, Horvath, Attila, Steiner, Laszlo, Zahuczky, Gabor, Podani, Janos, Nagy, and Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064310/
https://www.ncbi.nlm.nih.gov/pubmed/23809696
http://dx.doi.org/10.1186/gm463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064310/
https://www.ncbi.nlm.nih.gov/pubmed/23809696
http://dx.doi.org/10.1186/gm463

Ejemplares similares